Registry to hold plate lottery in new branch
MassDOT Registrar of Motor Vehicles Celia J. Blue announced the annual low number license plate lottery drawing will be held on Sept. 10 from 4:30 p.m. to 6 p.m. at the RMV's soon-to-open branch at 136 Blackstone St. in Boston. The number "351" is included in the drawing this year; it is the number of cities and towns within the commonwealth.
The new branch space features a dedicated E-ZPass Service Customer Center, enhanced privacy during customer transactions and hearings, and consolidated licensing and registration counters.
The Boston Public Market is to be located on the first floor and the RMV will occupy the second and third floors.
Abercrombie's logos coming off
The Abercrombie & Fitch logo has lost the power it once wielded.
Shares of Abercrombie & Fitch Co. tumbled yesterday after reporting weak sales as more teens shop elsewhere. The New Albany, Ohio-based retailer reported that revenue fell 5.8 percent to $890.6 million, short of analyst estimates. Revenue at stores open at least a year dropped a steep 11 percent, including 8 percent at U.S. stores.
The company is trying to stock trendier clothing — and it turns out that means stripping off the once-prized Abercrombie logo.
It is a major change for the retailer, whose sweatshirts and T-shirts emblazoned with its name long held major cachet with teenagers. Now, individuality is the name of the game.
U.S. economy grew at 4.2 percent rate
After a bleak start to the year, the U.S. economy grew at a brisk annual rate of 4.2 percent in the April-June quarter, the government said yesterday, slightly faster than it had first estimated.
The upward revision supported expectations that the second half of 2014 will prove far stronger than the first half.
Today
L Commerce Department releases personal income and spending for July.
L Biogen Idec announced that Donald R. Johns, M.D., has joined the company as vice president, leading Biogen Idec's amyotrophic lateral sclerosis (ALS) Innovation Hub (ALS iHub). The ALS iHub is a new, cohesive unit dedicated to accelerating the discovery and development of novel therapies for ALS by integrating research with clinical development. Johns has spent more than 30 years researching and developing medicines for patients with neurodegenerative diseases. He has contributed to several successful new drug applications and has 14 patents in his name that are either issued or pending.
Do you have a new hire or promotion to announce? Send items with photos for The Shuffle to bizsmart@bostonherald.com.
Anda sedang membaca artikel tentang
The Ticker
Dengan url
https://warnakelabuabu.blogspot.com/2014/08/the-ticker_29.html
Anda boleh menyebar luaskannya atau mengcopy paste-nya
The Ticker
namun jangan lupa untuk meletakkan link
sebagai sumbernya
0 komentar:
Posting Komentar